dcaf7
6分前
Data from same day dosing trial will be presented at ACCC 51st Annual Meeting & Cancer Center Business Summit on March 5, 2025. Title: Eflapegrastim, a Long-Acting GCSF, Administered the Same Day as Chemotherapy in Patients with Early-Stage Breast Cancer: Results from a Multicenter, Open-Label, Stud
mouton29
7分前
style="caret-color: rgb(45, 49, 63); color: rgba(45, 49, 63, 1); font-family: "Noto Sans JP", ????, sans-serif; background-color: rgba(255, 255, 255, 1)"I had not focused on the timing, that the treatment in a challenge study (or at least, the Shinogi study) is administered BEFORE the intentional in